Skip to content
value.today

Scipher Medicine Corp

🇺🇸 Waltham, Massachusetts, USABiotechnologyFounded 2013

Formerly DZZOM Delaware Corp.

Total raised
$121 M
4 rounds on record
Latest round
$6 M
May 2024
First round on record
Aug 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Scipher Medicine Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$6 MNo. 4$2 to $10 million

Scipher Medicine Corp: Raise no. 4, May 2024

Investors in this round

1 investor had bought by the notice of Jul 30, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Reginald Seeto · Executive Officer, Director
  • Albert-Laszlo Barabasi · Director
  • Glenn Muir · Director
  • Ingo Chakravarty · Director
  • Joseph Loscalzo · Director
  • Miklos Kobor · Director
  • Samir Kaul · Director
  • Tim Anderson · Director
  • Todd Sone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Reginald Seeto, Chief executive officer and president. Source: SEC Form D, newest notice filed Jul 30, 2024. Read the notice at the SEC.

equity, optionsSEC
Mar 2021$82 MNo. 3$50 to $250 million

Scipher Medicine Corp: Raise no. 3, Mar 2021

Investors in this round

12 investors had bought by the notice of Mar 31, 2021: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$82 M of $82 M offered
Smallest investment taken
$80,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alif Saleh · Executive Officer, Director
  • Jeffrey Sachs · Executive Officer
  • Albert Laszlo Barabasi · Director
  • Joseph Loscalzo · Director
  • Michael Rubin · Director
  • Miklos Kobor · Director
  • Samir Kaul · Director
  • Todd Sone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None except for normal operation expenses”

Signed by Jeffrey Sachs, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Mar 31, 2021. Read the notice at the SEC.

equitySEC
May 2019$25 MNo. 2$10 to $50 million

Scipher Medicine Corp: Raise no. 2, May 2019

Investors in this round

15 investors had bought by the notice of Oct 10, 2019: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alif Saleh · Executive Officer, Director
  • Byron Kalogerou · Executive Officer
  • Albert Laszlo Barabasi · Director
  • Joseph Loscalzo · Director
  • Michael Rubin · Director
  • Miklos Kobor · Director
  • Samir Kaul · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None except for normal operation expenses”

Signed by Alif Saleh, Chief Executive Officer and President. Source: SEC Form D and 1 amendment, newest notice filed Oct 10, 2019. Read the notice at the SEC.

equitySEC
Aug 2018$9 MNo. 1$2 to $10 million

Scipher Medicine Corp: Raise no. 1, Aug 2018

Investors in this round

11 investors had bought by the notice of Aug 17, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$342,500
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alif Saleh · Executive Officer, Director
  • Byron Kalogerou · Executive Officer
  • Albert Laszlo Barabasi · Director
  • Joseph Loscalzo · Director
  • Miklos Kobor · Director
  • Samir Kaul · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • COVINGTON ASSOCIATES, LLC (CRD 127437) · Boston, MassachusettsSold in CA, IL, MA, NC, NY, WA, and outside the US

Remarks in the notice

  • On the use of proceeds: “None except for normal operation expenses”

Signed by Alif Saleh, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Aug 17, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Scipher Medicine Corp chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2024

That is all the official record says: Scipher Medicine Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Scipher Medicine Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Scipher Medicine Corp
NameRoleNamed in
Reginald SeetoExecutive officerJul 2024
Alif SalehExecutive officerMar 2021
Jeffrey SachsExecutive officerMar 2021
Byron KalogerouExecutive officerOct 2019
Albert-Laszlo BarabasiDirectorJul 2024
Glenn MuirDirectorJul 2024
Ingo ChakravartyDirectorJul 2024
Joseph LoscalzoDirectorJul 2024
Miklos KoborDirectorJul 2024
Reginald SeetoDirectorJul 2024
Samir KaulDirectorJul 2024
Tim AndersonDirectorJul 2024
Todd SoneDirectorJul 2024
Albert Laszlo BarabasiDirectorMar 2021
Alif SalehDirectorMar 2021
Michael RubinDirectorMar 2021